# Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

Study · id `cardio:ct-nct04040452` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04040452](<https://clinicaltrials.gov/study/NCT04040452>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04040452

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 166 participants.

## Technical summary

Registry record NCT04040452. Randomized; triple masking; primary purpose supportive care. Start 2021-03-01 (actual); primary completion 2027-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 166 participants (planned count; ClinicalTrials.gov record NCT04040452, source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)
- Started: 2021-03-01 (actual) (ClinicalTrials.gov record NCT04040452, source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)
- Primary completion: 2027-10-01 (anticipated) (ClinicalTrials.gov record NCT04040452, source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT04040452, source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04040452, source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04040452-2026-08-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- Acronym: CIVIK
- Condition: Congenital Heart Disease in Children
- Intervention (Drug): Continuous ketorolac
- Lead sponsor: Phoenix Children's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: 052641301990682c7a492fc779a2e0c02f6d05f7c662c444908e669119f8bb6a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
